• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down0.08% Nasdaq Up0.22%

    Keryx Biopharmaceuticals Inc. (KERX)

    5.59 Up 0.10(1.82%) Nov 27, 1:00PM EST
    Analyst OpinionGet Analyst Opinion for:
    Recommendation Summary*
    Mean Recommendation (this week):2.6
    Mean Recommendation (last week):2.6

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Price Target Summary
    Mean Target:10.91
    Median Target:11.00
    High Target:19.00
    Low Target:2.50
    No. of Brokers:11

    Data provided by Thomson/First Call

    Upgrades & Downgrades History
    DateResearch FirmActionFromTo
    Aug 13, 2015Morgan StanleyInitiated Underweight
    Aug 11, 2015FBR CapitalInitiated Mkt Perform
    Aug 10, 2015ROTH CapitalDowngradeBuyNeutral
    Sep 8, 2014FBR CapitalDowngradeMkt PerformUnderperform
    Aug 14, 2014FBR CapitalInitiated Mkt Perform
    Mar 21, 2014MizuhoInitiated Buy
    Dec 13, 2012Maxim GroupInitiated Buy
    Nov 13, 2012Burrill Institutional ResearchInitiated Mkt Outperform
    May 10, 2012Ladenburg ThalmannUpgradeNeutralBuy
    Apr 3, 2012Ladenburg ThalmannDowngradeBuyNeutral

    More Upgrades & Downgrades for KERX

    Data provided by Briefing.com - Take a free trial
    Complete Live market analysis of the U.S. stock and bond markets, technology stocks, economic releases, earnings reports, and day trading highlights.

    Recommendation Trends
    Current MonthLast MonthTwo Months AgoThree Months Ago
    Strong Buy3333

    Data provided by Thomson/First Call

    Currency in USD.